G6PC2 and type 2 diabetes mellitus: Future studies will also use Vanderbilt University’s BioVU biobank to examine whether SNPs that affect human G6PC2 protein expression or activity are associated with altered phenotypic characteristics in humans, such as FBG and T2D risk.